BioLife Solutions Inc. made a $1 million investment in Savsu Technologies Inc., increasing its ownership stake in the company to 31% from 26%.
Albuquerque, N.M.-based Savsu Technologies manufactures hardware and software solutions designed to protect live cell therapies during transport and storage.
Following the transaction, BioLife CEO Michael Rice and CFO Roderick de Greef joined Savsu's board.
Bothell, Wash.-based BioLife Solutions manufactures and sells hypothermic storage and cryopreservation solutions for cells and tissues.
